Longboard Pharmaceuticals Inc (LBPH): Rasio kapitalisasi pasar marang pendapatan
Longboard Pharmaceuticals is shaping the treatment landscape for rare brain pathologies by establishing standards of care for epilepsy. The company is implementing software robots for clinical analysis and automating molecule screening. Drug development is based on a virtual model utilizing external manufacturing facilities in the US. The divergence of the P/S ratio from its historical average demonstrates valuation dynamics, where the metric serves as the target level.
Rincian analitis perusahaan Longboard Pharma (LBPH)
- nilai saham lan prakiraan konsensus rega:
- data kapitalisasi bursa:
- indikator kapitalisasi buku:
- statistik kawajiban utang lan likuiditas:
Utang Agregat marang Ekuitas Longboard Pharmaceuticals|LBPH - Utang jangka dawa marang modal|Rasio tanggungan utang jangka cendhak marang modal Longboard|LBPH - Gunggung utang perusahaan|Utang-utang marang kapitalisasi buku Longboard Pharma|LBPH - Utang jangka dawa perusahaan|Silihan lan utang jangka cendhak perusahaan Longboard Pharmaceuticals|Indikator likuiditas cepet longboardpharma.com
- indikator pendapatan resik lan kelipatan nilai:
LBPH - Bathi resik|Proyeksi bathi mangsa ngarep Longboard Pharmaceuticals|LBPH - Pangali P/E|Prakiraan rega marang bathi Longboard Pharmaceuticals Inc|LBPH - Pangali PEG|Nilai perusahaan marang bathi sadurunge bunga, pajeg, lan panyusutan Longboard Pharma|LBPH - Bathi operasional sadurunge ngurangi amortisasi|Bathi resik saben saham (EPS TTM) Longboard Pharmaceuticals|LBPH - Bathi resik saben saham sajrone 12 wulan pungkasan|Kacepetan wutah bathi saben saham taun-ka-taun sajrone rolas wulan pungkasan longboardpharma.com|LBPH - Wutah bathi ing taun lumaku|Prakiraan konsensus wutah bathi saben saham kanggo taun ngarep Longboard Pharmaceuticals
- indikator pendapatan dodolan lan penghasilan bisnis:
Analisis umum perusahaan:LBPH longboardpharma.com
The P/S ratio relates the market value of Longboard Pharmaceuticals (LBPH) to its annual revenue, revealing the gap between stock quotes and actual cash flows. Analyzing the price-to-sales ratio allows for an assessment of the biotech's capitalization fairness, where the potential of bexicaserin in epilepsy therapy and the prospect of acquisition by pharma behemoths may justify a high premium over current sales.
Pesaing Longboard Pharmaceuticals
Multiplikator P/S biogen.com (BIIB)|Rasio rega marang pendapatan Neurocrine Biosciences, Inc. NBIX|Rasio kapitalisasi pasar marang pendapatan RGC|Axsome Therapeutics Inc - Multiplikator P/S|ACAD (ACADIA Corp) - Rasio kapitalisasi marang pendapatan|XENE (Xenon Pharmaceuticals) - Kapitalisasi marang pendapatan|vikingtherapeutics.com - Rasio kapitalisasi pasar marang pendapatan|Rasio rega marang pendapatan Supernus|Catalyst Pharma - Rasio rega marang dodolan|Multiplikator P/S DNLI|HRMY (Harmony Corp) - Rasio kapitalisasi pasar marang pendapatan|Multiplikator P/S BHVN (Biohaven Ltd.)|Multiplikator P/S amylyx.com AMLX|TRVI - Rasio rega marang pendapatan|Rasio kapitalisasi pasar marang pendapatan PRAX (Praxis Precision Medicines Inc)|Anavex Corp (AVXL) - Rasio rega marang pendapatan|Kapitalisasi marang pendapatan CeriBell EEG|PRTA (Prothena Biosciences) - Multiplikator P/S|Multiplikator P/S Alector Therapeutics|Multiplikator P/S ANNX|Kapitalisasi marang pendapatan omeros.com OMER|Multiplikator P/S NGNE (Neurogene Corp)|AC Immune Inc (ACIU) - Rega marang dodolan|VYGR: Kapitalisasi marang pendapatan|NMRA - Multiplikator P/S|SCLX (Scilex) - Kapitalisasi marang pendapatan|TVGN: Kapitalisasi marang volume dodolan|ACOG (Alpha Cognition Inc) - Multiplikator P/S|Cognition Therapeutics Inc. (CGTX) - Koefisien rega marang pendapatan|Multiplikator P/S IKT|Kapitalisasi marang pendapatan cassavasciences.com SAVA|Multiplikator P/S ASRT (Assertio)|Multiplikator P/S Coya Therapeutics Inc COYA|VTGN - Rasio rega marang pendapatan|OVID: Rasio rega marang pendapatan|Acumen Pharmaceuticals (ABOS) - Rasio rega marang pendapatan|CRVO - Koefisien rega marang pendapatan|Rasio rega marang pendapatan Alterity Therapeutics Ltd.|Rasio rega marang pendapatan CLNN|Multiplikator P/S PEPG|Rasio rega marang pendapatan JUNS (Jupiter Neurosciences, Inc.)|Rasio rega marang pendapatan Relmada Therapeutics RLMD|ANVS (annovisbio.com) - Rasio rega marang dodolan|Grace Tx - Multiplikator P/S|Rasio kapitalisasi pasar marang pendapatan AIFF (Firefly Neuroscience, Inc.)|anewmeds.com (KLTO) - Rasio rega marang pendapatan|Rasio kapitalisasi marang pendapatan NRSN|RVPH (Reviva Pharmaceuticals) - Multiplikator P/S|Rega marang dodolan MetaVia, Inc. MTVA|Kapitalisasi marang pendapatan NRXS (NeurAxis)|Multiplikator P/S heliusmedical.com (HSDT)|Rasio rega marang pendapatan Passage Bio PASG|Rasio kapitalisasi pasar marang pendapatan NEUP|NERV - Rasio rega marang pendapatan|Rega marang dodolan athira.com|Addex Therapeutics Ltd (ADXN) - Rasio rega marang pendapatan|ALZN (Alzamend Neuro) - Rasio rega marang pendapatan|Rasio rega marang pendapatan Cyclerion Therapeutics Inc.|Rega marang dodolan Protagenic PTIX|Rasio rega marang pendapatan Pasithea Therapeutics (KTTA)|cortigent.com - Rasio kapitalisasi marang pendapatan|Multiplikator P/S ATXI (Avenue Therapeutics, Inc.)|Multiplikator rega marang pendapatan Brainstorm Cell Therapeutics Inc.|Cara Therapeutics, Inc - Multiplikator P/S|CHRO: Rasio rega marang pendapatan|eliemtx.com (ELYM) - Rasio rega marang pendapatan|Rega marang dodolan Intra-Cellular Therapies, Inc. (ITCI)|MRNS (Marinus Pharmaceuticals, Inc.) - Multiplikator P/S|Multiplikator P/S NKGen Biotech Inc|Rasio rega marang pendapatan NeuroBo (NRBO)|SAGE (Sage Therapeutics Inc) - Rasio kapitalisasi pasar marang pendapatan|Multiplikator P/S SNPX (Synaptogenix, Inc.)|TRVN: Rasio kapitalisasi marang pendapatan|VIGL: Kapitalisasi marang pendapatan|Rasio kapitalisasi pasar marang pendapatan WENA (anewmeds.com)|Cerevel (CERE) - Rasio rega marang pendapatan
